Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06011499 · ClinicalTrials.gov registry record · NA

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

A NA study of Prostate Carcinoma, sponsored by OHSU Knight Cancer Institute.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06011499: Recruiting NA study of Prostate Carcinoma, sponsored by OHSU Knight Cancer Institute.

NCT06011499 is a NA study of Prostate Carcinoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 250 participants, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06011499, a NA study of Prostate Carcinoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.

Primary Outcome

Measured from weight assessed on the Aria (registered trademark) scale at the time of the online assessment and self-reported height. Overweight is defined as body mass index \> 25 kg/m\^2 and a 5% loss will be viewed as a successful outcome.

Conditions Studied

Interventions

  • OTHER Internet-Based Exercise Intervention
  • OTHER Internet-Based Diet Intervention
  • OTHER Education Intervention

Study Locations (2)

Alabama

  • University of Alabama - Birmingham

Oregon

  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-12
Est. Completion 2027-12-31
Phase NA
OHSU Knight Cancer Institute

211 total trials

What NCT06011499 shows while recruiting

NCT06011499 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Internet-Based Exercise Intervention is the first listed.

NCT06011499 reports a single indexed study location in Alabama, Oregon.

Frequently Asked Questions

What is clinical trial NCT06011499 about?

NCT06011499 is a clinical study titled "Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE". This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight g...

What is the current status of trial NCT06011499?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-12. Estimated completion is 2027-12-31.

What conditions does trial NCT06011499 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT06011499?

The interventions under investigation include: Internet-Based Exercise Intervention (OTHER), Internet-Based Diet Intervention (OTHER), Education Intervention (OTHER).

Who is sponsoring clinical trial NCT06011499?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06011499 being conducted?

This trial has 2 study locations across Alabama, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06011499's enrollment target sits among peer trials

250 14th of 59 higher than 45 of 59 other Prostate Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06011499, the US trial registry maintained by the National Library of Medicine. NCT06011499 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.